BioMr. Flaherty has served as a Behrman Capital Operating Partner since March 2009. He has more than 35 years of operating experience in the healthcare field, with particular expertise in the clinical laboratory environment. Previously, Mr. Flaherty was President and CEO of Athena Diagnostics, a Behrman Capital portfolio company which was sold to Fisher Scientific after three years. Prior to joining Athena, he held a se ....
Education